Sanofi Files 6-K Report for April 2025
Ticker: SNYNF · Form: 6-K · Filed: Apr 24, 2025 · CIK: 1121404
| Field | Detail |
|---|---|
| Company | Sanofi (SNYNF) |
| Form Type | 6-K |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update
TL;DR
Sanofi dropped a 6-K filing on April 24, 2025, with a press release attached. Keep an eye on Exhibit 99.1.
AI Summary
On April 24, 2025, Sanofi filed a Form 6-K, reporting on events for the month of April 2025. This filing includes a press release, attached as Exhibit 99.1, which is incorporated by reference into the report.
Why It Matters
This filing provides an update on Sanofi's activities and disclosures for the period, which is important for investors to stay informed about the company's ongoing operations and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily incorporates a press release, indicating no immediate significant new risks are being disclosed.
Key Players & Entities
- Sanofi (company) — Registrant
- 001-31368 (company) — SEC File Number
- April 2025 (date) — Reporting period
- 20250424 (date) — Filing date
- Exhibit 99.1 (document) — Attached press release
FAQ
What is the primary purpose of this Form 6-K filing by Sanofi?
The primary purpose is to report on events for the month of April 2025, specifically incorporating a press release as Exhibit 99.1.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on April 24, 2025.
What is the SEC file number for Sanofi?
Sanofi's SEC file number is 001-31368.
What period does this report cover?
This report covers the month of April 2025, with a conformed period of report as of March 31, 2025.
What is included as an exhibit in this filing?
A press release, designated as Exhibit 99.1, is included and incorporated by reference.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 24, 2025 regarding Sanofi (SNYNF).